New hope for kids with severe arthritis: drug shows promise in reducing symptoms and steroid use
NCT ID NCT00339157
First seen Feb 20, 2026 · Last updated Jun 17, 2026 · Updated 19 times
Summary
This study tested a drug called anakinra in 24 children and young adults (ages 2-20) with severe systemic juvenile idiopathic arthritis that did not respond well to steroids. For the first month, half received anakinra and half received a placebo, then all received anakinra for 11 more months while slowly reducing steroids. The goal was to see if anakinra could improve arthritis symptoms and help patients use less steroids over a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bordeaux CHU
Bordeaux, 33000, France
-
Hopital Lyon Edouard Herriot
Lyon, 69437, France
-
Kremlin-Bicetre Hospital
Paris, 94270, France
-
Nancy Hopital d'Enfants
Nancy, 54511, France
-
Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants Malades Hospital, 149 rue de Sevres
Paris, 75015, France
-
Robert Debre Hospital
Paris, 75019, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.